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Abstract
In environmental exposure studies, it is common to observe a portion of exposure measurements to 
fall below experimentally determined detection limits (DLs). The reverse Kaplan-Meier (RKM) 
estimator, which mimics the well-known Kaplan-Meier estimator for right-censored survival data 
with the scale reversed, has been recommended for estimating the exposure distribution for the 
data subject to DLs because it does not require any distributional assumption. However, the RKM 
estimator requires the independence assumption between the exposure level and DL and can lead 
to biased results when this assumption is violated. We propose a kernel-smoothed nonparametric 
estimator for the exposure distribution without imposing any independence assumption between 
the exposure level and DL. We show the proposed estimator is consistent and asymptotically 
normal. Simulation studies demonstrate that the proposed estimator performs well in practical 
situations. A colon cancer study is provided for illustration.
Keywords
detection limits; left-censored data; environmental exposure; kernel smoothing; nonparametric 
estimator
1. Introduction
In environmental exposure studies, one fundamental question is to estimate distributions of 
environmental chemicals, such as trace elements and pesticides, in a certain population. 
However, it is very common to observe a portion of exposure measurements to fall below 
experimentally determined detection limits (DLs). A detection limit (DL) is “a threshold 
below which measured values are not considered significantly different from a blank signal, 
at a specified level of probability” [1]. Therefore, the exposure level of a chemical for a 
*Correspondence to: Li Chen, Biostatistics and Bioinformatics Shared Resource Facility, Markey Cancer Center and Department of 
Biostatistics, College of Public Health, University of Kentucky, Lexington, USA. Tel: 859-323-2005. 
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sample is only reported when its value is not less than the DL and otherwise is reported as a 
less than value or non-detect. The DL itself can depend on the mass/volume of the analyzed 
sample and/or on the mass/volume of adjustment factors such as lipid content. The 
laboratory may report a common DL for all samples or different DLs for different samples. 
When the latter occurs, it is mostly because the mass/volume of the obtained sample and/or 
any adjustment factor differs for each individual, and the exposure level and DL may be 
associated in this case. For example, in the colon cancer study measuring trace element 
accumulation in toenails [2], we observed a statistically significant association between the 
exposure level and DL in Appalachian cancer cases for at least 6 trace elements (Table 4). 
This may be because trace elements can cause adverse effects on metabolism and therefore 
lead to slow growth rate of toenails [3]. As a result, toenail samples obtained from 
individuals with high exposure to trace elements tend to have low masses, and thus high 
DLs. Conversely, a higher toenail mass results in a lower DL (i.e., a better ability to detect 
low levels of metal accumulation). In this situation, the exposure level and DL are positively 
associated whereas both are negatively associated with the toenail sample mass.
Ad hoc methods, such as substituting DL, DL/2, or DL/√2 for the value below a DL, are 
widely used in environmental science literature to estimate the exposure distribution for the 
data subject to DLs. However, these methods have no theoretical basis and are ill-advised 
unless relatively few measures fall below DLs [4; 5]. To appropriately account for values 
below DLs, parametric models for left-censored data, such as the lognormal model [1], can 
be used since the data subject to DLs can also be treated as left-censored data [1]. But these 
parametric methods can lead to markedly biased results when the parametric form of the 
exposure distribution is misspecified [1; 5]. Recently nonparametric methods have received 
increasing attention because they do not require distributional assumptions, and thus may be 
a safer choice for data analysis. The reverse Kaplan-Meier (RKM) estimator, which mimics 
the Kaplan-Meier (KM) estimator for right-censored survival data with the scale reversed, 
has been recommended [6]. Note that both the RKM estimator and the aforementioned 
parametric methods require the independence assumption between the exposure level and 
DL. To our knowledge, there are no appropriate statistical methods available to deal with the 
case when the exposure level and DL are associated.
In this paper, we utilize a two-step strategy and the kernel smoothing technique to develop a 
nonparametric consistent estimator for the exposure distribution allowing for the situation 
that the exposure level and DL are not independent. We first estimate the conditional 
exposure distribution given the DL by adding kernel weights into the RKM estimator and 
then obtain the average of the estimated conditional distributions over all DL values in the 
sample to estimate the marginal exposure distribution. The proposed method does not 
require any independence assumption between the exposure level and DL and any 
distributional assumption about the exposure level. In Section 2, we propose the estimator 
and show that it is consistent and converges weakly to a Gaussian process. In Section 3, the 
results of several simulation studies are reported to compare the performance of the 
proposed estimator to both the RKM estimator and a parametric estimator assuming a 
lognormal exposure distribution. In Section 4, a colon cancer study is provided for 
illustration. Finally, Section 5 contains discussions and some extensions.
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2. Methods
Let T̃ and D be random variables for the exposure level and DL, respectively, and F(·) be the 
cumulative distribution function (CDF) of the exposure level. Let T = max(T̃, D) and δ = I(T̃ 
≥ D). Here δ indicates whether T is an exposure level value or a DL value. For data subject 
to DL, only (T, δ, D) are observable for each subject. Suppose the data consist of n 
replicates {(Ti, δi, Di): i = 1, ⋯, n}. Note that the method proposed below requires the DL to 
be known for each subject in the data.
It is useful to adopt the counting process notation. Analogous to the observed counting 
process and at-risk process for right censored survival data, we define two counting 
processes, Ni(t) = I(Ti ≤ t, δi = 1) and Yi(t) = I(Ti ≤ t), for the data subject to DLs. Then the 
RKM estimator can be rewritten as
(1)
where τn = mini=1,…,n{Ti}. In addition, when the smallest observation is uncensored, 
F̂RKM(t) = 0 for t ∈ (0, τn). When the smallest observation is censored, F̂RKM(t) is undefined 
for t ∈ (0, τn). This estimator mimics the KM estimator for right-censored survival data with 
the scale reversed. Similar to the independence assumption between the survival time and 
censoring time for the KM estimator, the RKM estimator requires the independence 
assumption between the exposure level and DL and is not a consistent estimator when this 
assumption is violated.
To develop a consistent estimator for the exposure distribution allowing for the association 
between the exposure level and DL, we propose a two-step strategy based on the statistical 
fact that F(t) = ED{F(t; D)}, where F(t; d) is the conditional CDF of the exposure level given 
the DL, i.e. F(t; d) = Pr(T̃ ≤ t | D = d), and ED is the expectation with respect to D. In the 
first step, we obtain a consistent estimator for the conditional CDF of the exposure level, 
denoted by F̂(t; d). Specifically, we estimate the conditional CDF by adding kernel weights 
into the RKM estimator in equation (1) such that subjects whose DL values closest to d 
receive the largest weights, i.e.
where K(·) is a kernel function, and h is a bandwidth such that nh → ∞ and nh4 → 0 as n 
→ ∞. For each value of d, all subjects contribute to the calculation of F̂(t; d) but with 
different weights depending on the difference between their DL values and d. In the second 
step, we estimate F(t) by the average of estimated conditional CDF values over all DL values 
in the sample, i.e. . Similar to the RKM estimator, the proposed 
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estimator F̂(t) is a right-continuous step function with jumps at uncensored observations. 
When the smallest observation is uncensored, F̂(t; d) = 0 and F̂(t) = 0 for t ∈ (0, τn). When 
the smallest observation is censored, F̂(t; d) and F̂(t) are undefined for t ∈ (0, τn). The above 
estimator for the conditional CDF borrows the idea of the kernel conditional KM estimator 
which added kernel weights into the KM estimator to estimate the conditional survival 
function for right-censored survival data [7]. In the following, the proposed estimator F̂(t) 
will be referred to as KRKM estimator. Through the above two-step strategy, in order for 
F̂(t) to be a consistent estimator for the marginal CDF of the exposure level, we only need 
the estimator for the conditional CDF given the DL to be a consistent estimator, which only 
requires the conditional independence between the exposure level and DL given the DL. 
Since it is true that the exposure level and DL are independent given the DL, the KRKM 
estimator is consistent without requiring any independence assumption between the 
exposure level and DL. We show in Appendix A that √n{F̂(t) − F(t)} converges weakly to a 
zero-mean Gaussian process and is asymptotically equivalent to the process 
, where
(2)
The above theoretic result does not require the kernel function to have any special shape. But 
numerically, because the kernel function appears in the denominator of the proposed 
estimator, standard kernel functions, such as Gaussian kernel with fixed standard deviation 
and Triangular kernel, can produce extremely small kernel weights and thus cause unstable 
results. Therefore, to ensure computational stability, we suggest using the following 
modified Silverman kernel [8], which is flatter and less likely to produce extremely small 
kernel weights,
For the bandwidth, we suggest using σ̂n−1/3, where σ̂2 is the sample variance of the DL. This 
choice satisfies the conditions that nh → ∞ and nh4 → 0 as n → ∞. Based on the formula 
in (2), the variance of the KRKM estimator can be estimated by , where ξ̂i(t) 
is obtained by replacing F(·; Di) and F(·) by F̂(·; Di) and F̂(·). The log-log transformed 95% 
confidence intervals for F(t) can then be calculated as that for the survival function in 
survival analysis. This will be referred to as formula-based variance estimation method. 
Another approach to estimate the variance is to use the bootstrap method. Similar log-log 
transformed 95% confidence intervals can be obtained. This approach will be referred to as 
bootstrap-based variance estimation method. The formula-based variance estimation method 
is computationally faster than the bootstrap-based method, but may underestimate the 
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variance and thus yield poor coverage probabilities at the points below which there are few 
observations, as shown in simulation studies of Section 3.
We have implemented the proposed methods in an R package called “KENDL”, which is 
now available at the Comprehensive R Archive Network. (https://cran.r-project.org/web/
packages/KENDL/index.html).
3. Simulation studies
To assess the performance of the proposed KRKM estimator under the situation that the 
exposure level and DL are associated, we mimicked the cadmium (Cd) and nickel (Ni) data 
in Appalachian cases from the colon cancer study in Section 4. We generated the DL for 
each trace element based on their empirical distributions in the data and the exposure level 
for each trace element from the lognormal regression model: log(T̃) = μ + βlog(D) + σε, 
where ε follows a standard normal distribution. The parameters μ, β, σ are estimated based 
on the data for each trace element, which are −3.05, 0.42, and 1.21 for Cd (setting 1) and 
0.16, 0.34, and 1.62 for Ni (setting 2). The non-detect rate of the simulated data is 76% and 
25% for the above two settings, respectively. We compared the KRKM estimator, with both 
bootstrap-based and formula-based variance estimation, to the RKM estimator and the 
parametric estimator assuming a lognormal distribution for the exposure level. The latter two 
estimators were obtained from NADA R package. Note that the NADA package has an error 
in reporting the RKM estimator for the CDF, which is described below. Let t(1) < ⋯ < t(m) be 
the ordered unique uncensored exposure values. The RKM estimator at a given uncensored 
exposure value t(i), i.e. F̂RKM(t(i)), should be the NADA-reported CDF estimate at t(i+1). 
Therefore, we corrected this error by letting F̂RKM(t(i)) be the NADA-reported CDF estimate 
at t(i+1). For any t ∈ [t(i), t(i+1)), we set F̂RKM(t) equal to F̂RKM(t(i)) since F̂RKM(.) is a right-
continuous step function. Table 1 summarizes the results for the above three estimators of 
F(t) at t = 1st, 2nd and 3rd quartiles based on 1000 replicates and 500 bootstraps for both 
settings. The proposed KRKM estimator with the bootstrap-based variance estimation 
performs very well except for t = 1st quartile in setting 1: the biases are small and the 
confidence intervals have proper coverage probabilities. At t = 1st quartile in setting 1, the 
coverage probability is lower than the nominal value due to the very high non-detect rate of 
76%. Compared to the bootstrap-based variance estimation, the formula-based variance 
estimation for the KRKM estimator is computationally faster. But at the points below which 
there are few observations, e.g. t = 1st and 2nd quartiles in setting 1, the formula-based 
variance estimation tends to underestimate the variance and thus yield poor coverage 
probabilities. In contrast to the KRKM estimator, the RKM estimator has large biases and 
poor coverage probabilities, especially when the sample size increases, due to its inability to 
account for the association between the exposure level and DL. Likewise, the lognormal 
estimator also has large biases and low coverage probabilities, resulting from not accounting 
for the association between the exposure level and DL and possibly misspecified exposure 
distribution. To further unravel the impact of not accounting for the association between the 
exposure level and DL for the lognormal estimator, we considered additional simulations 
where the DL for each trace element was generated from a lognormal distribution with 
parameters estimated from the colon cancer data. Under this scenario, the marginal 
distribution of the exposure level is guaranteed to follow a lognormal distribution so that the 
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parametric distribution is correctly specified for the lognormal estimator. However, as shown 
in Table 2, the lognormal estimator still yields large biases and poor coverage probabilities.
To compare the performance of the KRKM, RKM and lognormal estimators under the 
situation that the exposure level and DL are independent, we adopted the above set-up but 
set β = 0. The non-detect rate of the simulated data is 78% and 31% for the two settings, 
respectively. Table 3 summarizes the results for the KRKM, RKM and lognormal estimators 
of F(t) at t = 1st, 2nd and 3rd quartiles based on 1000 replicates and 500 bootstraps. For all 
the estimators, the biases are very small, the variance estimators are accurate and the 
confidence intervals have proper coverage probabilities. The KRKM estimator obtains 
comparable results as the RKM estimator when the exposure level and DL are independent. 
The lognormal estimator yields slightly smaller variances than the KRKM and RKM 
estimators, which is expected since the exposure level and DL are independent and the 
exposure distribution is lognormal under this set-up.
4. Example
Kentucky has the nation's highest colon cancer incidence rate [10]. Appalachian Kentucky, 
which has a unique geology that contains high-quality bituminous coal naturally rich in trace 
elements, has an even higher rate of colon cancer compared to other regions of the state. A 
case-control study was conducted to explore the association between environmental 
exposures to trace elements such as arsenic (As), chromium (Cr) and nickel (Ni) and colon 
cancer and whether exposures to these trace elements contribute to the elevated colon cancer 
rate in Appalachian Kentucky [11; 2]. For this purpose, 274 colon cancer cases and 253 
controls were selected from 23 contiguous rural counties in Kentucky (Appalachian region) 
and Jefferson County, the largest, most urban county in Kentucky (non-Appalachian region). 
Among 247 subjects from the Appalachian region, 145 were cases and 102 were controls; 
among 280 from the non-Appalachian region, 129 were cases and 151 were controls. 
Toenail samples from these subjects were collected, and the concentrations of 12 trace 
elements were measured as markers of long-term environmental exposures to these trace 
elements. The DL varies from one subject to another for these trace element concentrations 
as a function of the toenail mass. For illustration purposes, we only focus on the 
Appalachian region. The proportion below the DL is over 20% for most trace elements and 
is as high as 79% and 83% for Cd in Appalachian cases and controls, respectively (Table 4).
We first examine the independence assumption between the exposure level and DL for each 
trace element using the following three methods. In the first method, we fitted a lognormal 
accelerated failure time (AFT) model [12] with the left-censored exposure level as the 
outcome and the log-transformed DL as a covariate. Under this model, the independence 
assumption between the exposure level and DL was examined by testing whether the 
coefficent is equal to 0. The Pearson's correlation coefficient between the exposure level and 
DL (both log-transformed) was estimated by , where β̂, σ̂ are the estimators 
of the coefficient and scale parameters in the lognormal AFT model and  is the sample 
variance of log(D). In the second method, the Pearson's correlation coefficient between the 
exposure level and DL (both log-transformed) and the corresponding p-value were 
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calculated based on the “clikcorr” R package, which assumes a bivariate normal distribution 
for the two variables and uses a profile likelihood method [13]. In the third method, the 
nonparametric Kendall's tau correlation coefficient [14] and the corresponding p-value were 
calculated based on the “cenken” function in the NADA R package [9]. The results based on 
the above three methods are reported in Table 4. The results from the first two parametric 
methods are vey close for all trace elements except for Cd in controls, where the non-detect 
rate is as high as 83%. For colon cancer cases, there is a statistically significant association 
between the exposure level and DL for all 12 trace elements based on the two parametric 
methods. The nonparametric Kendall's tau method, which appears more conservative, 
identifies 6 trace elements with a significant association between the exposure level and DL. 
For controls, there is only one trace element showing a significant association between the 
exposure level and DL based on the three methods.
We then use the trace element Ni to demonstrate our proposed KRKM estimator, comparing 
to the RKM estimator and the parametric estimator. For cases, the Ni level ranges from 0.02 
to 624.4 and the DL ranges from 0.004 to 24.84; for controls, the Ni level ranges from 0.04 
to 39.37 and the DL ranges from 0.01 to 38.38. Table 4 shows that for Ni there is a 
signifcant association between the exposure level and DL for cases but no signficant 
association for controls. We estimated the exposure distributions of Ni level for cases and 
controls, respectively. The lognormal distribution was selected for the distributions of Ni for 
both cases and controls by the Akaike information criterion (AIC) [15] among a number of 
candidate distributions, including normal, lognormal, Weibull and loglogistic. Figure 1 
displays the CDF estimates for colon cancer cases and controls based on the KRKM, RKM 
and lognormal estimators, and Figure 2 displays the differences in CDF estimates between 
the KRKM estimator and the latter two estimators along with 95% confidence limits. These 
figures show that the RKM estimator significantly overestimates the CDF for the Ni level 
between 0.21 and 5.29 compared to the proposed KRKM estimator for cancer cases. This 
may be because of the significant association between the exposure level and DL. In 
contrast, there is no significant difference between the two estimators for controls, which 
may be because of the insignificant association between the exposure level and DL. As a 
result, the RKM estimator significantly underestimates the difference between the cases and 
controls compared to the KRKM estimator. Figures 1 and 2 also show remarkable difference 
between the lognormal and KRKM estimators for cases, most likely due to a combination of 
imperfect fit of the lognormal distribution and the significant association between the 
exposure level and DL. The difference between these two estimators is smaller for controls.
5. Discussion
We have developed a consistent nonparametric estimator for the exposure distribution 
without requiring any independence assumption between the exposure level and DL. Our 
proposed estimator outperforms the RKM estimator and the parametric estimator when the 
exposure level and DL are associated because the latter two estimators are not consistent in 
that situation. In the case of a common DL, our estimator reduces to the RKM estimator; and 
in the case of varying DLs but the exposure level and DL are independent, our estimator can 
obtain comparable results as the RKM estimator. Thus, our estimator provides a unified 
nonparametric approach for estimating the exposure distribution regardless of whether the 
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exposure level and DL are independent or not and whether the association between the 
exposure level and DL is linear, curvilinear, or step function, etc. Therefore, the user does 
not have to test whether the exposure level and DL are associated before using our method, 
which is an advantage over the RKM method whose validity depends on the test results.
We have utilized a two-step strategy and kernel smoothing technique along with a special 
feature of data subject to DLs, i.e. the DL is observable for each subject, to completely 
eliminate the independence assumption between the exposure level and DL. In contrast, the 
consistent estimators developed based on similar two-step strategies for the marginal 
survival function for right-censored survival data need to find a set of covariates and require 
the independence assumption between the censoring time and survival time conditional on 
those covariates [16; 17]. In our approach, we take advantage of the data characteristic that 
the DL is observable for each subject and utilize the DL as the conditioning covariate. As a 
statistical fact, the independence assumption between the DL and exposure level given the 
DL automatically holds. Therefore, our estimator is free of any independence assumption 
between the exposure level and DL.
In survival analysis, another approach dealing with dependent censoring for estimating the 
survival function is the inverse probability of censoring weighting (IPCW) KM estimator 
[18; 19]. This weighted version of the KM estimator assigns a weight, inversely proportional 
to an estimate of the conditinal survival function of the censoring time given a set of 
covariates, to each subject. Under the condition that the censoring time and survival time are 
independent given that set of covariates, the IPCW KM estimator is consistent. By 
borrowing this idea, one can construct an IPCW RKM estimator for the exposure 
distribution by adding subject-specific weights, proportional to each subject's conditional 
CDF of the DL given a set of covariates, in the RKM estimator. The consistency of this 
estimator requires that the exposure level and DL are independent given that set of 
covariates. However, it is not possible to use the IPCW method with DL as the covariate to 
obtain an estimator free of any independence assumption between the exposure level and 
DL. The conditional CDF of the DL, given DL, can only take values 0 or 1 and thus cannot 
be used as an inverse weight.
A key issue in our two-step strategy is how to estimate the conditional CDF of the exposure 
level given the DL for the data subject to DL. To address this issue, we have added kernel 
weights into the RKM estimator. The use of the kernel technique assures our estimator is 
purely nonparametric and free of any distributional assumption. Importantly, our estimator 
does not suffer the curse of dimensionality of the kernel method because we only need to 
condition on a one-dimensional variable, i.e. the DL, for estimating the conditional CDF. In 
addition, our estimator is robust to the choice of bandwidth. Besides the bandwidth of σ̂n−1/3 
presented in the paper, we also conducted simulation studies using several other bandwidths 
including σ̂n−7/24, σ̂n−2/5, and σ̂n−1/2, which yielded very similar results (data not shown). 
As an alternative to the kernel method, one can use a parametric AFT model with the left-
censored exposure value as the outcome and the DL as the covariate to estimate the 
conditional CDF. Additional simulation studies reveal that this alternative method performs 
well and has smaller variance than the proposed estimator when the model is correctly 
specified but can lead biased results when the model is misspecified (data not shown).
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In this paper, we highlight the critical need to account for the association between the 
exposure and DL and the consequences of ignoring it. This problem of association between 
the exposure and DL may sometimes be alleviated by improving the design of sample 
collection. For example, the association between the DL and the exposure level in the colon 
cancer study could have been reduced if toenail samples had been collected from multiple 
toes or at multiple time points to obtain larger samples and thus lower the DLs. Having equal 
DLs for all subjects would eliminate any association, and may be feasible in some settings 
but logistically difficult in others. In presence of varying DLs, appropriate statistical 
methods should be used to deal with the possible association between the exposure level and 
DL so that unbiased analysis results can be obtained.
There are at least two extensions of the proposed method. First, the proposed KRKM 
estimator requires the data come from a simple random sample of the underlying population. 
One can extend the proposed estimator to survey data by incorporating sampling weights. 
Second, our estimator can serve as the building block for a formal test to compare the 
exposure distributions between two groups by considering the cumulative weighted 
difference in CDF estimates for the two groups, analogous to the weighted KM statistics for 
right-censored data [20]. However, it will be more complex than the latter because the 
proposed KRKM estimator is more complicated than the KM estimator. Of further interest is 
to incorporate the adjustment of confounding factors in the comparison between two groups. 
Current literature [21; 22] considered logistic regression models with exposure(s) and 
confounding factors as covariates and the disease status as the outcome and used the 
maximum likelihood method to make inferences. However, these methods require the 
independence assumption between the exposure level and DL. One possible approach to 
account for the association between the exposure level and DL is to use multiple imputation 
to impute exposure values below DLs based on our kernel-smoothed conditional CDF given 
the DL. Since our kernel-smoothed conditional CDF is undefined in (0, τn) when the 
smallest observation is censored, additional distributional assumptions are needed for that 
region in order to perform the imputation under this situation.
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Appendix A
Weak convergence of √n{F̂(t) − F(t)}
In this section, we prove the weak convergence of √n{F̂(t) − F(t)} through the modern 
empirical process theory. Let Pn and P denote the empirical measure and the distribution 
under the true model, respectively. For a measurable function f and measure Q, the integral 
∫fdQ is abbreviated as Qf. Specifically, , P{f(T, δ, D) 
is the expectation of f(T, δ, D), and P{f(T, δ, D)|D} is the conditional expectation of f(T, δ, 
D) given D. We express √n{F̂(t) − F(t)} as
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(3)
To study the second term in (3), we define
By some algebras we obtain R(t; d) = −logF(t; d), which is analogous to the conditional 
cumulative hazard function in survival analysis but with the conditional survival function 
replaced by the conditional CDF. We first study
Let N(t) = I(T ≤ t, δ = 1) and Y(t) = I(T ≤ t). We express R̂(t; d) − R(t; d) as
(4)
It's straightforward to show that the first term on the right side of (4) is equal to
By Lemma 1 and some algebras, the second term on the right side of (4) is equal to
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By Lemma 1 and the statistical fact that T̃ and D is independent given D, the third term on 
the right side of (4) can be shown to be O(h2). Therefore, we obtain that R̂(t; d) − R(t; d) is 
equal to
By the condition that √nh2 = op(1), the Duhamel equation and Lemma 1, we obtain that the 
second term on the right side of (3) is asymptotically equivalent to
where D* is a random variable with the same distribution as D, and PD* denotes expectation 
only respective to D*.
Similarly, we can verify that P{F̂(t; D) − F(t; D)}2 →p 0 uniformly for t ∈ [0, ∞] and that 
F̂(t; D), F(t; D) belong to a P- Donsker class. It then follows that the third term of (3) 
converges uniformly to zero in probability by Lemma 19.24 of[23].
Combining the aforementioned results, we conclude that √n(F̂(t) − F(t)) is asymptotically 
equivalent to the process
Lemma 1. Let fD (d) be the probability density function of D, then
Proof: We have
(5)
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Let g(x) = P[δI(T ≥ t) | D = x]fD(x). Using a simple transformation s = (x − d)/h and the 
Taylor expansion of g(d + sh) at d, we obtain the right side of (5) is equal to
(6)
Because ∫ K(s)ds = 1 and ∫ sK(s)ds = 0, we then obtain the first equation. Similarly, we can 
obtain the second equation.
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Figure 1. 
CDF estimates of Ni exposure distribution for colon cancer cases vs. controls in the 
Appalachian region based on the KRKM, RKM, and lognormal estimators. The solid curves 
pertain to the CDF estimates for cases and the dotted curves pertain to those for controls. 
The red curves are for the KRKM estimator, the blue curves are for the RKM estimator, and 
the green curves are for the lognormal estimator.
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Figure 2. 
Differences in CDF estimates of Ni exposure distribution between the RKM and KRKM 
estimators (upper panel) and between the lognormal and KRKM estimators (lower panel), 
along with 95% confidence limits. The solid curves are for the point estimates of 
differences, and the dotted curves are for the corresponding 95% bootstrapped confidence 
limits (CLs). The black curves pertain to the cases and the orange ones petain to the 
controls.
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